Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 214

1.

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.

Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, Thom KA, Cosgrove SE, Sakoulas G, Perencevich EN.

BMC Infect Dis. 2011 Oct 19;11:279. doi: 10.1186/1471-2334-11-279.

PMID:
22011388
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Is cefazolin inferior to nafcillin for treatment of methicillin-susceptible Staphylococcus aureus bacteremia?

Lee S, Choe PG, Song KH, Park SW, Kim HB, Kim NJ, Kim EC, Park WB, Oh MD.

Antimicrob Agents Chemother. 2011 Nov;55(11):5122-6. doi: 10.1128/AAC.00485-11. Epub 2011 Aug 8.

PMID:
21825299
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study.

Hall RG 2nd, Giuliano CA, Haase KK, Hazlewood KA, Frei CR, Forcade NA, Brouse SD, Bell T, Bedimo RJ, Alvarez CA.

BMC Infect Dis. 2012 Apr 27;12:104. doi: 10.1186/1471-2334-12-104.

PMID:
22540223
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysis-dependent patients with methicillin-susceptible Staphylococcus aureus bacteremia.

Stryjewski ME, Szczech LA, Benjamin DK Jr, Inrig JK, Kanafani ZA, Engemann JJ, Chu VH, Joyce MJ, Reller LB, Corey GR, Fowler VG Jr.

Clin Infect Dis. 2007 Jan 15;44(2):190-6. Epub 2006 Dec 8.

PMID:
17173215
[PubMed - indexed for MEDLINE]
Free Article
5.

Outcome of vancomycin treatment in patients with methicillin-susceptible Staphylococcus aureus bacteremia.

Kim SH, Kim KH, Kim HB, Kim NJ, Kim EC, Oh MD, Choe KW.

Antimicrob Agents Chemother. 2008 Jan;52(1):192-7. Epub 2007 Nov 5.

PMID:
17984229
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The impact of vancomycin susceptibility on treatment outcomes among patients with methicillin resistant Staphylococcus aureus bacteremia.

Honda H, Doern CD, Michael-Dunne W Jr, Warren DK.

BMC Infect Dis. 2011 Dec 5;11:335. doi: 10.1186/1471-2334-11-335.

PMID:
22142287
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Prevalence and outcomes of antimicrobial treatment for Staphylococcus aureus bacteremia in outpatients with ESRD.

Chan KE, Warren HS, Thadhani RI, Steele DJ, Hymes JL, Maddux FW, Hakim RM.

J Am Soc Nephrol. 2012 Sep;23(9):1551-9. doi: 10.1681/ASN.2012010050. Epub 2012 Aug 16.

PMID:
22904350
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The empirical combination of vancomycin and a β-lactam for Staphylococcal bacteremia.

McConeghy KW, Bleasdale SC, Rodvold KA.

Clin Infect Dis. 2013 Dec;57(12):1760-5. doi: 10.1093/cid/cit560. Epub 2013 Aug 28. Review.

PMID:
23985343
[PubMed - indexed for MEDLINE]
9.

Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus.

Wang JL, Chen SY, Wang JT, Wu GH, Chiang WC, Hsueh PR, Chen YC, Chang SC.

Clin Infect Dis. 2008 Mar 15;46(6):799-806. doi: 10.1086/527389.

PMID:
18266610
[PubMed - indexed for MEDLINE]
Free Article
10.

High vancomycin minimum inhibitory concentration is a predictor of mortality in meticillin-resistant Staphylococcus aureus bacteraemia.

Wi YM, Kim JM, Joo EJ, Ha YE, Kang CI, Ko KS, Chung DR, Song JH, Peck KR.

Int J Antimicrob Agents. 2012 Aug;40(2):108-13. doi: 10.1016/j.ijantimicag.2012.04.003. Epub 2012 May 26.

PMID:
22633565
[PubMed - indexed for MEDLINE]
11.

Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children.

Martínez-Aguilar G, Hammerman WA, Mason EO Jr, Kaplan SL.

Pediatr Infect Dis J. 2003 Jul;22(7):593-8.

PMID:
12867833
[PubMed - indexed for MEDLINE]
12.
13.

Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus.

Shurland S, Zhan M, Bradham DD, Roghmann MC.

Infect Control Hosp Epidemiol. 2007 Mar;28(3):273-9. Epub 2007 Feb 15.

PMID:
17326017
[PubMed - indexed for MEDLINE]
14.

Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia?

Paul M, Zemer-Wassercug N, Talker O, Lishtzinsky Y, Lev B, Samra Z, Leibovici L, Bishara J.

Clin Microbiol Infect. 2011 Oct;17(10):1581-6. doi: 10.1111/j.1469-0691.2010.03425.x. Epub 2010 Dec 14.

PMID:
21073629
[PubMed - indexed for MEDLINE]
15.

Empiric guideline-recommended weight-based vancomycin dosing and nephrotoxicity rates in patients with methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study.

Hall RG 2nd, Hazlewood KA, Brouse SD, Giuliano CA, Haase KK, Frei CR, Forcade NA, Bell T, Bedimo RJ, Alvarez CA.

BMC Pharmacol Toxicol. 2013 Feb 13;14:12. doi: 10.1186/2050-6511-14-12.

PMID:
23402420
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Staphylococcus aureus bacteremia in older adults: predictors of 7-day mortality and infection with a methicillin-resistant strain.

Bader MS.

Infect Control Hosp Epidemiol. 2006 Nov;27(11):1219-25. Epub 2006 Sep 29.

PMID:
17080380
[PubMed - indexed for MEDLINE]
17.

Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia.

Mascitti KB, Edelstein PH, Fishman NO, Morales KH, Baltus AJ, Lautenbach E.

Infect Control Hosp Epidemiol. 2012 Feb;33(2):160-6. doi: 10.1086/663708. Epub 2011 Dec 20.

PMID:
22227985
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations.

Holmes NE, Turnidge JD, Munckhof WJ, Robinson JO, Korman TM, O'Sullivan MV, Anderson TL, Roberts SA, Gao W, Christiansen KJ, Coombs GW, Johnson PD, Howden BP.

J Infect Dis. 2011 Aug 1;204(3):340-7. doi: 10.1093/infdis/jir270.

PMID:
21742831
[PubMed - indexed for MEDLINE]
Free Article
19.

Early response assessment to guide management of methicillin-resistant Staphylococcus aureus bloodstream infections with vancomycin therapy.

Joo J, Yamaki J, Lou M, Hshieh S, Chu T, Shriner KA, Wong-Beringer A.

Clin Ther. 2013 Jul;35(7):995-1004. doi: 10.1016/j.clinthera.2013.05.018. Epub 2013 Jul 2.

PMID:
23829982
[PubMed - indexed for MEDLINE]
20.

Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.

Chang FY, Peacock JE Jr, Musher DM, Triplett P, MacDonald BB, Mylotte JM, O'Donnell A, Wagener MM, Yu VL.

Medicine (Baltimore). 2003 Sep;82(5):333-9.

PMID:
14530782
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk